Therapies Targeting Metastasis

• 2226 · PDF Novel targeted therapies for malignant ascites in pancreatic cancer Kuntal Halder, Ruben Munoz, Wei Lin, Annie Yang, Yanghee Woo, Erkut Borazanci, Haiyong Han, Daniel D Von Hoff
• 2227 Selectively eliminating senescent cancer-associated fibroblasts via chidamide and chemo-immunotherapy in metastatic pancreatic cancer: phase 2 clinical trial results (PANDA-1706) Tianxing Zhou, Jingrui Yan, Jihui Hao
• 2228 · PDF Biofield therapy inhibits pancreatic cancer invasion and metastasis by modulating multiple steps of metastatic cascade Peiying Yang, Sharmistha Chakraborty, Phuong Nguyen, Defeng Deng, Amanda Eckstrom, Andrew Cusimano, Daoyan Wei, Lorenzo Cohen
• 2229 · PDF RIPK2 and CDK2 form a targetable positive feedback loop in prostate cancer cells Ahmed Elgehama, Jaceline Pires Sanches Sanches, Lili Guerra, Wei Yang
• 2230 · PDF Combined treatment with agonists for CXCR4 and CB2 receptors reduces prostate cancer growth and metastasis Nakea Michelle Pennant, Alifiani Bonita Hartono, Shiqin Liu, Sidharth Paparaju, Chung Lee, Christopher Massey, Tanya Ivanova Stoyanova, Cimona V. Hinton
• 2231 · PDF Resensitizing therapy-resistant anoxic metastatic melanoma cells Gustavo Untiveros, Daryl Forney, Mariella Andrews, Tekaswini Kannan, Luigi Strizzi
• 2232 · PDF Investigating the combined inhibition of RAF, MEK, and FAK in melanoma molecular subtypes Jared Almazan
• 2233 · PDF Novel anticancer mechanisms of melanin: Effects on cancer cell adhesion, survival, and migration Dorie Liu, Wei Zhu
• 2234 · PDF Antibodies that bind to primitive human growth factor NME7-AB block interaction with MUC1* growth factor receptor to inhibit cancer growth and metastasis Cynthia Carol Bamdad, Benoit J. Smagghe, Mark G. Carter, Kevin R. Yi, Michael J. Nash, Trevor J. Grant, Daniel S. Miller, Natalie K. Miller, Andrew K. Stewart
• 2235 · PDF Intercepting metastasis: 8-step CRISPR design via multi-modal foundation models Fahad Kiani
• 2236 · PDF Evaluation of novel medicinal compounds for therapeutic efficacy against liver cancer Aarya M. Tripathi, Veerababu Nagati, Yamile AbuchardAnaya, Kaylee Renteria, Denise Soto, Miguel Salazar, Subhash C. Chauhan, Debasish Bandyopadhyay
• 2237 · PDF Novel MACC1 transcriptional inhibitor act via reduced NFκB signaling pathway to reduce metastasis formation Ulrike S. Stein
• 2238 · PDF Anti-metastatic properties of the triterpene diosgenin on lung carcinoma cells Laurie Mar Santos, Edwin Figueroa, Juan Figueroa, Yamixa Delgado, Daraishka Pérez, Yancy Ferrer
• 2239 · PDF The transcobalamin receptor, CD320, is a therapeutic target for metastatic triple negative breast cancer Joanne Tejero, Felicia Lazure, Stanislav Drapela, Eduardo Miranda, Nadir Sarigul, Devesh Raizada, Didem Ilter, Ana Gomes
• 2240 · PDF Inhibition of STAT3 and PARP1 reduces TNBC invasion through cytoskeletal remodeling Arielle McGlone, Ali Andalibi, Pranabananda Dutta
• 2241 · PDF Galectin 1 as a regulator of hormone driven mammary remodeling and early dissemination with therapeutic potential in breast cancer Magali Berton, Ramiro Perrotta, Luis Valencia Salazar, Tomás Dalotto Moreno, Yamil D. Mahmoud, Juan Manuel Perez Saez, Sabrina Gatto, Rosa Morales, Julio Aguirre-Ghiso, Gabriel A. Rabinovich, Mariana Salatino
• 2242 · PDF Dual TTK/PLK1 inhibition combined with G-CSF treatment synergistically suppresses metastatic progression in triple-negative breast cancer Sunwoong Kim, Hanyoung Kim, Sung-Dae Cho, Jaehan Lee, Mi Kyung Park, Minkyung Kang, Seunghyun Ma, Hee-Joo Choi, Jeong-Yeon Lee
• 2243 · PDF Lasofoxifene is a bone protective treatment option for estrogen receptor positive breast cancers Emily Kate Zboril, David C. Boyd, Rachel K. Myrick, Nina Dashti-Gibson, Faith E. Parker, Carson Walker, Amy Olex, Chuck Harrell
• 2244 · PDF Pro-metastatic kinase network inhibition to treat drug-resistant triple-negative breast cancer Margarite Matossian, Madeline Henn Bungert, Kent Schechter, Long Chi Nguyen, Michael East, Denis O. Okumu, Rita Nanda, Gary L. Johnson, Marsha R. Rosner
• 2245 · PDF DNMTi in combination with PARPi inhibits aberrant Wnt/beta-catenin signaling and tenasin-C pathways, cancer stemness and metastasis in triple negative breast cancer Lora Stojanovic, Kaushlendra Tripathi, Zahra Gohari, Julia L. Rutherford, Saranya Rajendran, Tara X. Metcalfe, Shu Zhang, Stephen B. Baylin, Michael Topper, Kenneth P. Nephew, Feyruz V. Rassool
• 2246 GLUT3 inhibition reduces metastatic potential of triple-negative breast cancer cells by modulating cell mechanics via the TEAD-VASP-Actin axis Seeun Oh, Wonkyung Lee, Song Kim, Donghoon Yoon, Jun-Yong Choe, Tae-Hyung Kim
• 2247 · PDF Intracellular complement signaling plays a critical role in s1p/s1pr1 mediated inflammasome activation and tumor metastasis Salih Gencer, Alhaji H. Janneh, Natalia Oleinik, Charles Chalfant, Besim Ogretmen
• 2248 · PDF Inhibition of the mitochondrial antioxidant response blocks ex vivo lung colonization in pediatric osteosarcoma Elli Maria Tiliakou, Michael Lizardo, Yue-Zhou Huang, Taras Shyp, Poul Sorensen

在完整检索应用中浏览本分会场 →